Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học 'Respiratory Research cung cấp cho các bạn kiến thức về ngành y đề tài: Influence of hypoxia on the domiciliation of Mesenchymal Stem Cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies . | Respiratory Research BioMed Central Research Open Access Influence of hypoxia on the domiciliation of Mesenchymal Stem Cells after infusion into rats possibilities of targeting pulmonary artery remodeling via cells therapies Gael Y Rochefort1 Pascal Vaudin2 3 Nicolas Bonnet4 Jean- Christophe Pages3 Jorge Domenech2 Pierre Charbord2 and Véronique Eder 1 Address 1LABPART-EA3852 IFR135 Université Francois Rabelais faculté de Médecine 10 boulevard Tonnellé 370032 TOURS France 2INSERM ESPRI-EA3588 IFR135 Université Francois Rabelais faculté de Médecine 10 boulevard Tonnellé 370032 TOURS France 3Virus pseudo-virus morphogenése et antigénicité EA3856 Université Francois Rabelais faculté de Médecine 10 boulevard Tonnellé 370032 TOURS France and 4Architecture du Tissu Osseux - Exercice Physique EA 3895 Université d Orléans- BP6749 45067 Orléans cedex 2 France Email Gael Y Rochefort - Pascal Vaudin - vaudin_p@ Nicolas Bonnet - bonnet@ Jean-Christophe Pages - pages@ Jorge Domenech - domenech@ Pierre Charbord - charbord@ Véronique Eder - eder@ Corresponding author Published 27 October 2005 Received 31 October 2004 Respiratory Research 2005 6 125 doi 1465-9921-6-125 Accepted 27 October 2005 This article is available from http content 6 1 125 2005 Rochefort et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Bone marrow BM cells are promising tools for vascular therapies. Here we focused on the possibility of targeting the hypoxia-induced pulmonary artery hypertension remodeling with systemic delivery of BM-derived mesenchymal stem cells MSCs into .
